Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C126558-5mg | 5mg | In stock | $56.90 | |
C126558-10mg | 10mg | In stock | $93.90 | |
C126558-25mg | 25mg | In stock | $211.90 | |
C126558-50mg | 50mg | In stock | $281.90 | |
C126558-100mg | 100mg | In stock | $450.90 | |
C126558-250mg | 250mg | In stock | $1,014.90 |
VR1 antagonist
Synonyms | capsazepine|138977-28-3|N-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide|capasazepine|capsazepin|N-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide|CHEMBL391997|LFW48MY |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Capsazepine is a specific vanilloid receptor antagonist; synthetic analog of capsaicin.VR1 vanilloid receptor antagonist (IC 50 = 562 nM). Analgesic in vivo . |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | CHANNEL BLOCKER |
Mechanism of action | Channel blocker of TRPM8;Channel blocker of TRPV1 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Capsazepine is a synthetic analogue of the sensory neurone excitotoxin, capsaicin; potent TRPV1 receptor antagonist with IC50 of 562 nM. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488192405 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488192405 |
IUPAC Name | N-[2-(4-chlorophenyl)ethyl]-7,8-dihydroxy-1,3,4,5-tetrahydro-2-benzazepine-2-carbothioamide |
INCHI | InChI=1S/C19H21ClN2O2S/c20-16-5-3-13(4-6-16)7-8-21-19(25)22-9-1-2-14-10-17(23)18(24)11-15(14)12-22/h3-6,10-11,23-24H,1-2,7-9,12H2,(H,21,25) |
InChi Key | DRCMAZOSEIMCHM-UHFFFAOYSA-N |
Canonical SMILES | C1CC2=CC(=C(C=C2CN(C1)C(=S)NCCC3=CC=C(C=C3)Cl)O)O |
Isomeric SMILES | C1CC2=CC(=C(C=C2CN(C1)C(=S)NCCC3=CC=C(C=C3)Cl)O)O |
WGK Germany | 3 |
PubChem CID | 2733484 |
Molecular Weight | 376.9 |
PubChem CID | 2733484 |
---|---|
ChEMBL Ligand | CHEMBL391997 |
BindingDB Ligand | 20284 |
Wikipedia | Capsazepine |
CAS Registry No. | 138977-28-3 |
RCSB PDB Ligand | 6ET |
PubChem SID | 488192405 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2219280 | Certificate of Analysis | Jan 04, 2024 | C126558 |
H2330227 | Certificate of Analysis | Jun 30, 2023 | C126558 |
H2330182 | Certificate of Analysis | Jun 30, 2023 | C126558 |
H2330181 | Certificate of Analysis | Jun 30, 2023 | C126558 |
H2330180 | Certificate of Analysis | Jun 30, 2023 | C126558 |
E2306160 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306167 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306166 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306165 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306163 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306162 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306159 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306157 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306155 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306154 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306152 | Certificate of Analysis | Mar 30, 2023 | C126558 |
E2306151 | Certificate of Analysis | Mar 30, 2023 | C126558 |
A1908149 | Certificate of Analysis | Sep 13, 2022 | C126558 |
A2213055 | Certificate of Analysis | Jan 26, 2022 | C126558 |
C2219278 | Certificate of Analysis | Dec 28, 2021 | C126558 |
Solubility | 25°C: DMSO |
---|---|
Refractive Index | 1.67 |
Boil Point(°C) | 581.13° C at 760 mmHg |
Melt Point(°C) | 159-161°C |
WGK Germany | 3 |
---|
1. Ryskamp DA, Witkovsky P, Barabas P, Huang W, Koehler C, Akimov NP, Lee SH, Chauhan S, Xing W, Rentería RC et al.. (2011) The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells.. J Neurosci, 31 (19): (7089-101). [PMID:21562271] |
2. Cahusac PM & Noyce R. (2007) A pharmacological study of slowly adapting mechanoreceptors responsive to cold thermal stimulation.. Neuroscience, 148 (2): (489-500). [PMID:17683869] |
3. Adinolfi B et al.. (2013) Anticancer activity of anandamide in human cutaneous melanoma cells.. Eur J Pharmacol, 718 (1-3): (154-9). [PMID:24041928] |
4. Landucci E et al.. (2011) CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.. Neuropharmacology, 60 (4): (674-82). [PMID:21130785] |
5. Yan J et al.. (2011) Dural afferents express acid-sensing ion channels: a role for decreased meningeal pH in migraine headache.. Pain, 152 (106-13). [PMID:20971560] |
6. de Man JG et al.. (2008) Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors.. Neurogastroenterol Motil, 20 (5): (546-56). [PMID:18194153] |
7. De Schepper HU et al.. (2008) TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.. Am J Physiol Gastrointest Liver Physiol, 294 (G245-53). [PMID:17991707] |